Written on 01/01/16
Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid.
Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid.
References
Arthritis
Bone Metabolism
Ca Metabolism
Cancer
Cancer Vaccine
Cardiology
Cardiovascular
Cell Biology
CRISPER/Cas9
Development
Diabetes
Dual Expressor
Epidermis
Extra Cellular Matrix
Fusion Protein
Gene Correction
General
Hypoxia
Immunology
In vivo Imaging
Lipid Metabolism
miRNA/shRNA
Muscle
Neuro Science
Pulmonary
RAPAd
Renal
Smooth Muscle
Super Oxides
Tissue Specific Expression
Vaccine
Vascular
Wound Healing
Links
- Recombinant DNA and Gene Transfer Office of Biotechnology Activities http://www4.od.nih.gov/oba/Rdna.htm
- Aldevron http://www.aldevron.com/
- Bio Research Products http://www.bio-researchprod.com/home.html
- Elmira Biologicals Inc. http://www.elmirbiol.com
- Genetel Laboratories LLC http://www.genetel-lab.com/
- Midwest Bio Services http://www.midwestbioservices.com/
- Nature Technology Corporation http://www.natx.com
- Trans Ova Genetics http://www.transova.com/
Contact us
PO Box 525, North Liberty, IA 52317
Phone: 319-665-4190 | Fax: 319-665-4191
help@viraquest.com
